Form D · Biotechnology
Spring Bank Pharmaceuticals, Inc.
Hopkinton, MA · CIK 0001566373
Offering snapshot reported Nov 23, 2016 · SEC filing
- Reported sold
- $15M Offering amount: $15M
- Investors reported
- 24 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 23, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 23, 2016 | Initial | $15,000,001 | No comparison | 24 | SEC filing |
| Feb 27, 2015 | Amendment | $21,647,967 | $10,085,799vs Jan 14, 2015 | 72 | SEC filing |
| Jan 14, 2015 | Initial | $11,562,168 | No comparison | 25 | SEC filing |
| Feb 3, 2014 | Initial | $6,333,250 | No comparison | 36 | SEC filing |
| Jan 25, 2013 | Initial | $4,200,000 | No comparison | 43 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $900K (estimated)
- Finders' fees
- $0
- Form D file number
- 021-275100
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| William Blair & Company, L.L.C. | 1252 |
Source: Form D, filed Nov 23, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Nezam Afdhal | Executive |
| David Arkowitz | Director |
| Jonathon Ellsworth Bates | Director |
| Jonathan Bates | Director |
| Gregg Beloff | Executive |
| Michael Francis Cronin | Executive |
| Martin Driscoll | Director, Executive |
| Kurt M. Eichler | Director |
| Jonathan Freve | Executive |
| Radhakrishnan Parameswaran Iyer | Director, Executive |
| R.P. Kris Iyer | Director |
| Douglas John Jensen | Director, Executive |
| Guy Macdonald | Director |
| Donald Moore Mitchell | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
86 South Street
Hopkinton, MA, 01748
Hopkinton, MA, 01748